The Society for Obstetric Anesthesia and Perinatology (SOAP) commissioned a consensus document on the topic of neuraxial procedures in the context of thrombocytopenia. The following professional bodies were included: American Society of Regional Anesthesia and Pain Medicine (ASRA), ACOG, SMFM, and the American Society for Hematology (ASH). The panel was convened to address an ongoing issue where obstetric patients with thrombocytopenia are often denied neuraxial anesthesia due to risk of spinal epidural hematoma. However, there are significant maternal and fetal risks associated with general anesthesia during pregnancy.
Note: For more information on thrombocytopenia in pregnancy including etiologies and management, see ‘Related ObG Topics’ below
Neuraxial Anesthesia: Thrombocytopenia-Related Spinal Henatoma
Risks Associated with General Anesthesia
We found no evidence from RCTs or non‐randomised studies on which to base an assessment of the correct platelet transfusion threshold prior to insertion of a lumbar puncture needle or epidural catheter
…clinicians and patients should engage in shared decision-making about the perceived competing risks/benefits of proceeding with or withholding neuraxial anesthesia in cases of severe thrombocytopenia and concurrent aspirin use
SOAP Thrombocytopenia Consensus Statement FINAL
Are you an
ObG Insider?
Get specially curated clinical summaries delivered to your inbox every week for free
Please log in to ObGFirst to access this page
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
It appears you don't have enough CME Hours to take this Post-Test. We no longer offer Hours.
You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site